C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

BioVaxys Provides Viral Vaccine Platform Program Update

Monday, November 30, 2020

BioVaxys Technology Corp is pleased to announce that it has received further data from its successfully completed murine model study demonstrating that immunizing mice with two doses of BVX its COVID vaccine candidate induced high levels of antibodie...

Prevail Therapeutics Receives European Commission Orphan Designation for PR006 for the Treatment of Frontotemporal Dementia

Monday, November 30, 2020

Prevail Therapeutics Inc a biotechnology company developing potentially diseasemodifying AAVbased gene therapies for patients with neurodegenerative diseases today announced that the European Commission has granted orphan designation for PR for the t...

Forxiga approved in Japan for chronic heart failure

Monday, November 30, 2020

AstraZenecas Forxiga dapagliflozin has been approved in Japan for the treatment of patients with chronic heart failure HF who are receiving standard of careHF is a lifethreatening chronic disease that prevents the heart from pumping sufficient levels...

Zymeworks Receives FDA Breakthrough Therapy Designation for HER2-Targeted Bispecific Antibody Zanidatamab in Patients with Biliary Tract Cancer

Monday, November 30, 2020

Zymeworks Inc a clinicalstage biopharmaceutical company developing multifunctional biotherapeutics announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation for zanidatamab in patients with previouslytreated...

Ipsen receives FDA Fast Track designation for investigational irinotecan liposome injection (ONIVYDE®) as a second-line monotherapy treatment for small cell lung cancer (SCLC)

Monday, November 30, 2020

Ipsen announced the United States Food and Drug Administration FDA has granted the company Fast Track designation for irinotecan liposome injection ONIVYDE in study patients with small cell lung cancer SCLC who progressed following a firstline platin...

Air France KLM Martinair Cargo ready to distribute Covid-19 vaccines

Thursday, November 12, 2020

Since the rd week of March Air France KLM Martinair Cargo has made every effort to maintain its global airfreight network helping to keep vital supply chains in place This has always been essential but even more so since the outbreak of the Covid pa...

Foxx Life Sciences announces Opening of new Asia Headquarters in India!

Tuesday, November 17, 2020

Foxx Life Sciences announced on Tuesday that it will open the new international Asiaheadquarters in Medchal Hyderabad India The latest expansion comes with strong growth and performance in Asia and the continued expansion of Biopharmaceutical manufac...

Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021 according to new CPhI Report

Monday, November 30, 2020

A new report from CPhI explores the potential implications in of impending vaccine approvals a new administration in the White House and a return to dual supply chain strategiesThe report which summarises expert analysis into key findings foresee...

Eisai to Present Latest Data on Perampanel at the 74th American Epilepsy Society Annual Meeting

Monday, November 30, 2020

Eisai Co Ltd announced today that the company will present the latest data on its inhouse discovered and developed antiepileptic agent AED perampanel product name Fycompa at the th American Epilepsy Society Annual Meeting AES to be held virtually fro...

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

Monday, November 30, 2020

Eisai Co Ltd and Wren Therapeutics Ltd today announced that the companies have entered into an exclusive research collaboration agreement aiming to advance the discovery of novel small molecules that target alphasynuclein for the potential treatment...